Acquisition Announced

Ipsen acquisition of Kartos Therapeutics

US$450m consideration

Announced 29 Jun 2026

Advisers

Target
Kartos Therapeutics
Acquirer
Ipsen
Target based in
United States
Buyer based in
France
Sector
Biotech
Tags
Biotech, Oncology

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.